Table 2.
Baseline demographic and clinical characteristics by intervention group.
|
EXSa group (n=45) | SISb group (n=20) | P value |
Age (years), mean (SD) | 56.5 (5.7) | 56.5 (5.9) | .99 |
Education (years), mean (SD) | 12.9 (2.4) | 13.9 (2.2) | .14 |
Sex (male), n (%) | 32 (71) | 18 (90) | .10 |
BMI, mean (SD) | 30.5 (7) | 28.9 (5.7) | .39 |
Ethnicity (African American), n (%) | 29 (64) | 14 (70) | .81 |
Recent CD4 T-cell count (cells/mm3), median (IQR) | 581 (474-817) | 561 (362-771) | .47 |
CD4 nadir T-cell count (cells/mm3), median (IQR) | 195 (22-312) | 47 (25-358) | .84 |
CD8 T-cell count (cells/mm3), median (IQR) | 809 (489-1079) | 689 (577-1035) | .50 |
Duration of HIV infection (months), mean (SD) | 225.4 (117.6) | 259 (94.3) | .27 |
aEXS: aerobic and resistance exercise.
bSIS: social-interaction stretching.